Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report of KONE Corporation for January–March 2024

KONE Corporation, stock exchange release, April 24, 2024 at 8.30 a.m. EEST Interim Report of KONE Corporation for January–March 2024 Good start to the year with sales growth and improved profitability January–March 2024 · Orders received declined by 1.2% to EUR 2,235.7 (1–3/2023: 2,263.1) million. At comparable exchange rates, orders grew by 1.6%. · Sales grew by 0.5% to EUR 2,568.2 (2,556.6) million. At comparable exchange rates, sales grew by 2.7%. · Operating income (EBIT) was EUR 262.4 (238.3) million or 10.2% (9.3%) of sales. Adjusted EBIT was EUR 262.4 (241.9)

Interim report Q1 2024: High-strength steels resilient in a weak market

The first quarter · Revenue was SEK 27,148 (31,904) million · Operating result was SEK 3,157 (4,733) million · Earnings per share were SEK 2.57 (3.59) · Net cash was SEK 18.2 (15.6) billion · Investment decision of EUR 4.5 billion for fossil-free steel mill in LuleåComments by the CEO SSAB’s operating result for the first quarter of 2024 amounted to SEK 3,157 (4,733) million. The decrease compared to a year earlier was primarily due to US plate prices that reversed from a high level. The market in Europe continued to be relatively weak, whereas the market for high-

MTG reports strong Q1 with revenues up 11%, adjusted EBITDA up 51% and an operating margin of 27%

Our Q1 revenues grew by 11%, including a 1% uplift from currencies, to SEK 1,447 million, driven by PlaySimple’s established portfolio which now includes Word Search, the newly consolidated Snowprint and InnoGames’ successful live-ops. We reported a strong adjusted EBITDA of SEK 396 million and a margin of 27%. The performance was driven by the scale gained by PlaySimple in 2023, the lower cost base and growing browser revenues in InnoGames along with lower UA spending. Today, we also initiated our latest share repurchase program which will run until our 2024 AGM.Financial highlights Q1

New Sweco report: Europe’s green transition towards a resilient industry sector

Sweco’s latest expert report  outlines the progress of European industries in their efforts to become more resilient and move toward net zero. The steel industry is at the forefront, followed by the cement industry. The chemical and transport industries are also in the process of transforming toward net zero. As significant investments are made and new technologies such as hydrogen, CCS, and electrofuels are

Read original

Intrum AB – Interim results January-March 2024

· First quarter seasonally slow - in line with expectations and continued high commercial activity · Adjusted Income and adjusted EBIT both up 8 percent vs. Q1 ’23, driven by M&A in Servicing, specifically in Middle and Southern Europe · Leverage ratio flat at 4.4x, including 0.1x unfavourable FX movement · Progressed on several strategic initiatives including: (i) Ophelos operational in the Netherlands, (ii) realised savings of SEK ~500 M in Q1 ’24 (out of the SEK 800 M implemented in 2023), and implementing measures to save an additional SEK ~700 M in 2024 and 2025 and (iii) debt

MTG launches new SEK 100 million share repurchase program

Modern Times Group MTG AB (“MTG”) today announced that its Board of Directors has decided to launch a new share repurchase program of up to SEK 100 million. The program will run from 24 April 2024 up until and including 15 May 2024. The Board of Directors’ view is that the share repurchase program will provide a flexible and sustainable increase in the value created for MTG’s shareholders.MTG continues to have a strong balance sheet, and MTG’s Board of Directors has decided to launch a new share repurchase program of up to SEK 100 million to run up to and including 15 May 2024, being the

Lytix Biopharma AS - Last day of the Application Period

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, Norway, 24 April 2024: Reference is made to the stock exchange announcements published by Lytix Biopharma AS ("Lytix" or the "Company") on 9 April 2024 and 10 April 2024, regarding the launch of a partially guaranteed share

Interim report January–March 2024

Improved sequential performance in the wake of positive market sentimentKey highlights •    Adjusted EBITDA sequentially up more than 50%  •    Strengthened order books in both regions and improved capacity utilization in North America •    Sequentially 6% higher sales volumes (approx.+50 ktons)  •    Positive pricing and favorable mix changes compared to the fourth quarter •     Divestment of idled mill assets in the US  Quarterly data •    Net sales decreased by 9% to SEK 10,423 million (11,495) •    Adjusted EBITDA* SEK 1,166 million (1,484) •    Adjusted

INTERIM REPORT JANUARY – MARCH 2024

Well positioned for the gardening seasonFirst quarter 2024 · Net sales decreased by 14% to SEK 14,719m (17,167). Changes in exchange rates had a neutral effect.  · Planned exits of low-margin petrol-powered business impacted with -4%. Organic sales* decreased by 11%. · The Gardena Division achieved an organic growth of 2%. · Operating income was SEK 1,930m (2,364) and the operating margin was 13.1% (13.8).  · Earnings per share before dilution amounted to SEK 2.31 (2.90) and earnings per share after dilution amounted to SEK 2.31 (2.88). · Cash flow from operations and

Volvo Cars reports 8 per cent increase in Q1 2024 core operating profit to SEK 6.8 billion

·Q1 revenue was SEK 93.9 bn (SEK 95.7 bn in Q1 2023)  ·Q1 operating income (excl. JVs and associates) was SEK 6.8 bn (SEK 6.3 bn in Q1 2023)  ·Q1 EBIT margin (excl. JVs and associates) was 7.2 per cent (6.6 per cent in Q1 2023)  ·Q1 Basic earnings per share was SEK 1.12 (SEK 1.21 in Q1 2023)  ·Q1 fully electric car sales share at 21 per cent (18 per cent in Q1 2023)  Volvo Cars today reports an operating profit (EBIT) excluding joint ventures and associates of SEK 6.8 billion for the first quarter of 2024, an increase of 8 per cent versus the same period in

Ovako invests 15 million euros in Imatra Steel Mill

With the investment, Ovako modernizes the heavy bar mill of the Imatra site. This marks the largest investment in the Imatra mill in 30 years. As a result, the mill's production capacity will increase by 16,000 tons per year.The investment is an upgrade of the first and second rolling stand of the heavy bar mill and includes new transformers, motor drives, motors, and mechanical power lines.   The investment is significant not only for Ovako but also for Imatra and the entire South Karelia economic area, as it also will support employment for local and regional contractors.  "This

Read original

SEB’s results for the first quarter 2024

SEB’s operating profit for the first quarter 2024 amounted to SEK 12.3bn, with a return on equity of 17.2 per cent, a CET1 capital ratio of 18.9 per cent, and a capital management buffer of 420 basis points.  “We report a solid result, with robust asset quality and low net expected credit losses. The strengthening macroeconomic picture in Sweden was partly reflected in an improved market sentiment. At the same time, the high interest rate environment continued to have a dampening effect on credit demand,” says SEB’s President and CEO Johan Torgeby. Incomestatement

Finnish start-up Woodio, known for its ecological bathroom furniture, is investing in a new factory in Lahti, Finland – The investment is worth 7 million euros

Woodio's innovation, a 100% waterproof wood composite, is designed as an ecological alternative to ceramics and other high carbon footprint materials in bathroom and interior decoration. Last summer, Woodio raised over 16 million euros in growth capital to scale up its operations and expand internationally. With the new factory in Lahti, Finland, which will be completed in the spring of 2025 at a cost of approximately 7 million euros, production will be significantly streamlined to meet growing demand.Founded in Helsinki in 2015 and introducing its first products to the market in 2019,

Marion Ulander appointed Acting Country General Manager for Handelsbanken Norway

Marion Ulander has been appointed Acting Country General Manager for Handelsbanken Norway, succeeding Arild Andersen, who will now transition to a role as senior advisor to President and Chief Executive Officer, Michael Green. The recruitment process for a new permanent Country General Manager has already been initiated. Marion Ulander moves from her most recent position as Deputy Head of Handelsbanken Stockholm County. She will officially start in her new role on 1 May. “After conducting a thorough review of our Norwegian operations, we have decided on a strategic refocus. Now that we

Handelsbanken’s Interim Report January – March 2024

Q1 2024(Q4 2023) · Operating profit was SEK 8,267m (9,057). · Return on equity was 13.7% (15.2). · Earnings per share amounted to SEK 3.33 (3.66). · The C/I ratio was 42.2% (38.4). · The credit loss ratio was -0.01% (0.00). · The common equity tier 1 ratio was 18.8% (18.8). January – march 2024 (January – march 2023) · Operating profit was SEK 8,267m (8,516). · Return on equity was 13.7% (15.0). · Earnings per share amounted to SEK 3.33 (3.44). · The C/I ratio was 42.2% (38.5). · The credit loss ratio was -0.01% (0.01). · The common equity

Nordic Bioproducts Group opens its first major production facility for advanced cellulosic materials

Finnish startup Nordic Bioproducts Group has opened its state-of-the-art production facility in Lappeenranta, Finland. This facility, powered by the company’s proprietary AaltoCell™ Technology, is dedicated to the commercial-scale production of advanced cellulosic materials, including its flagship Microcrystalline Cellulose (MCC). The factory is expected to create 40 million euros in revenue in the first full operating year.HELSINKI, Finland (April 24th, 2024) - Nordic Bioproducts Group (NBG) , a leader in biomaterial innovation and developer of proprietary

First quarter 2024 results

Aker BP delivered continued strong operational performance in the first quarter of 2024, with low cost and low emissions, and with all field development projects progressing according to plan.  Highlights · Increased production: Oil and gas production reached 448 mboepd in the first quarter, one percent higher than in the fourth quarter · Low cost: Production cost amounted to USD 6.1 per barrel produced, down from USD 6.2 in the fourth quarter · Low emissions: Greenhouse gas emissions (scope 1&2) averaged 3.0 kg CO\2\e per boe, ranking among the lowest in the global oil & gas

Correction: Norconsult ASA - Annual Report 2023

Sandvika, 23 April 2024 (OSE: NORCO): Reference is made to the stock exchange notice published on 18 April 2024 - Annual report 2023: https://newsweb.oslobors.no/message/616057 An updated version of the Annual Report for 2023, including the Corporate Governance Reports and the Sustainability Report, along with the corresponding European Single Electronic Format (ESEF) file has been published today with a correction of note 7 Segments Reporting. The correction relates to the specification of 2023 numbers for the Denmark segment and Other- corporate cost and eliminations, and has no effect

Aker Solutions ASA: Transactions made under the buy-back programme

April 23, 2024 – On February 12, 2024, Aker Solutions ASA (“Aker Solutions”) announced a share buy-back program of up to NOK 500 million, with a maximum of 12.5 million shares, in the period from 12 February 2024 to 31 July 2024.DNB, acting under an irrevocable mandate from Aker Solutions, has carried out the following transactions under the buy-back program:   +-------------------------------+---------+-------------+--------------+| Date |Number of| Weighted | Total daily || | shares |average price| transaction ||

Good safety and improved erectile function reported from Dicot’s phase 1 study

Press release: Uppsala, April 23, 2024.  Dicot's completed phase 1 clinical study demonstrates that the company's drug candidate LIB-01 has a very good safety profile, which was the primary objective of the study. In addition to this, the company can deduce an efficacy signal from the study where participants reported an improved erectile function, in some cases beyond 28 days post first dose.The primary objective of Dicot's phase 1 study has been to investigate the safety profile in humans for LIB-01, the company’s drug candidate for treatment of erectile dysfunction. In January, Dicot

There are no items matching the current filter
There are no more items matching the current filter
Back to top